SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Harvey Allen who wrote (2888)6/11/1997 8:56:00 PM
From: John H. Farro   of 4342
 
I've been on vacation a few days so I haven't had a chance to comment on the latest press releases until now. Harvey you said:

"We were all wishing there was a short cut to eliminate
the capital required to bring a product to market. So now we
are forced to go the way John Babish wanted to go."

Actually, I am under the impression that Dr. Babish really wanted to go the dietary supplement route. He did not want to have to wait a few years for the full scale drug testing to get AndroVir and AndroCar out to market. I was surprised the FDA pulled the rug out from under PRLN like this and I wonder what would have happened if Dr. Babish had not been forced out of the company. I think Dr. Babish could have made a pretty persuasive case to the FDA that they should let PRLN go the Dietary Supplement route if they don't emphasize selling their products primarily to AIDS or Cancer patients. I don't know who gave the presentation to the FDA, but if it was Rhodes I doubt he could have given a strong presentation. This was clearly outside his area of expertise. Actually, I don't know what his area of expertise is, other than screwing up.

Robin
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext